OV-induced tumor immunity can be enhanced by the delivery of anti-tumor cytokines, such as IFNα, TNFα, IL-2, IL-12, and GM-CSF, while tumor-targeted cytokine delivery avoids the significant toxicity associated with systemic delivery while also boosting the immune response. Here, IFNA1 is linked to neoplasm.